Inhibition of the adipose ligase PNPLA2 has been associated with protection against ER stress in mice [39, 40], while activating genetic variants in PNPLA3 are associated with human NAFLD [41]. The gene discussed is PNPLA2; the disease is metabolic dysfunction-associated steatotic liver disease.